Post Author: Khushali Jhaveri, MD
Khushali S. Jhaveri is a hematologist-oncologist and assistant professor of medicine at the Indiana University School of Medicine, with clinical affiliation at the Indiana University Simon Comprehensive Cancer Center. She specializes in lymphoma, focusing on T-cell engaging therapies, outcomes in diffuse large B-cell lymphoma, and the impact of sarcopenia on treatment response. A former chief fellow for communication and wellness at Moffitt Cancer Center, Dr. Jhaveri also writes extensively on the intersection of medicine and society. Her work has appeared in ASH Clinical News, including the reflective piece “Redefining Home, Embracing Resilience: Life as an Immigrant in Medicine,” as well as in Medscape, where she explored evolving treatment paradigms in “Are We on the Brink of Redefining Follicular Lymphoma?” and addressed survivorship in “Cost of Survival: How Treatment Choices Shape Life After Cancer.”
You can follow her work at her website or connect via Instagram, X (Twitter), and LinkedIn.
Khushali S. Jhaveri is a hematologist-oncologist and assistant professor of medicine at the Indiana University School of Medicine, with clinical affiliation at the Indiana University Simon Comprehensive Cancer Center. She specializes in lymphoma, focusing on T-cell engaging therapies, outcomes in diffuse large B-cell lymphoma, and the impact of sarcopenia on treatment response. A former chief fellow for communication and wellness at Moffitt Cancer Center, Dr. Jhaveri also writes extensively on the intersection of medicine and society. Her work has appeared in ASH Clinical News, including the reflective piece "Redefining Home, Embracing Resilience: Life as an Immigrant in Medicine," as well as in Medscape, where she explored evolving treatment paradigms in "Are We on the Brink of Redefining Follicular Lymphoma?" and addressed survivorship in "Cost of Survival: How Treatment Choices Shape Life After Cancer."
You can follow her work at her website or connect via Instagram, X (Twitter), and LinkedIn.
“We’re six minutes in now, and she’s applied almost ten products.”
That’s how Dr. Molly Hales begins the video abstract for her recent Pediatrics study on TikTok skin care trends. The clip she’s referring to features a young girl layering product after product—acids, toners, serums—each promising glowier, cleaner, brighter skin.
This child isn’t an outlier. In a recent study analyzing 100 viral TikTok skin care videos posted by users aged 7 to …
Read more…
